Chinese cancer therapy developer Avistone raises $141m from Bain, others

Chinese cancer therapy developer Avistone raises $141m from Bain, others

Photo by Hal Gatewood on Unsplash

02 January, 2023

Edited by: Pramod Mathew

Avistone Biotechnology cancer CMG-SDIC Capital IDG Capital Oncology

Printed by Unregistered user on Wed, 11 Feb 2026 06:54:46 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

AstraZeneca to buy China's Gracell Biotechnologies in $1.2b deal

Temasek, HighLight Capital invest $210m in China’s VIVA Biotech

Read more from Greater China

ByteDance developing AI chip, in talks with Samsung for manufacturing

China’s Wuxi Lead stages muted Hong Kong debut after $627m offering